JY
FLGT icon

Jeff Yass’s Fulgent Genetics FLGT Stock Holding History

Jeff Yass’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.82M Buy
88,500
+39,600
+81% +$671K ﹤0.01% 6715
2026
Q1 		$778K Sell
48,900
-2,600
-5% -$56.4K ﹤0.01% 8541
2025
Q4 		$1.35M Buy
51,500
+26,900
+109% +$698K ﹤0.01% 6490
2025
Q3 		$556K Sell
24,600
-300
-1% -$6.18K ﹤0.01% 8712
2025
Q2 		$495K Buy
24,900
+8,400
+51% +$164K ﹤0.01% 9199
2025
Q1 		$279K Buy
+16,500
New +$281K ﹤0.01% 10222
2024
Q3 		– Sell
-15,200
Closed -$298K – 12290
2024
Q2 		$298K Sell
15,200
-22,500
-60% -$470K ﹤0.01% 9463
2024
Q1 		$818K Sell
37,700
-21,100
-36% -$524K ﹤0.01% 7364
2023
Q4 		$1.7M Sell
58,800
-230,700
-80% -$6.17M ﹤0.01% 5705
2023
Q3 		$7.74M Buy
289,500
+248,600
+608% +$8.49M ﹤0.01% 2887
2023
Q2 		$1.51M Sell
40,900
-37,200
-48% -$1.3M ﹤0.01% 5746
2023
Q1 		$2.44M Sell
78,100
-39,300
-33% -$1.26M ﹤0.01% 4739
2022
Q4 		$3.5M Sell
117,400
-51,600
-31% -$1.85M ﹤0.01% 3775
2022
Q3 		$6.44M Sell
169,000
-174,900
-51% -$8.77M ﹤0.01% 2774
2022
Q2 		$18.8M Buy
343,900
+101,800
+42% +$5.59M ﹤0.01% 1504
2022
Q1 		$15.1M Buy
242,100
+92,300
+62% +$6.08M ﹤0.01% 2020
2021
Q4 		$15.1M Sell
149,800
-106,000
-41% -$9.32M ﹤0.01% 2170
2021
Q3 		$23M Sell
255,800
-38,400
-13% -$3.49M ﹤0.01% 1832
2021
Q2 		$27.1M Buy
294,200
+31,900
+12% +$2.55M ﹤0.01% 1708
2021
Q1 		$25.3M Buy
262,300
+152,000
+138% +$15.7M ﹤0.01% 1624
2020
Q4 		$5.75M Buy
110,300
+28,700
+35% +$1.2M ﹤0.01% 3210
2020
Q3 		$3.27M Buy
+81,600
New +$2.55M ﹤0.01% 3715

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jeff Yass's FLGT Position: Q2 2026 in Review

Jeff Yass reduced its Fulgent Genetics (FLGT) stake by 20% in Q2 2026, selling an estimated $130K and leaving 30,405 shares worth $624K. The position accounts for ﹤0.01% of the portfolio, ranked #9385.

Jeff Yass first reported a position in FLGT in Q1 2018 and has held it in 26 quarters since. The position peaked at $15.2M in Q2 2021. 141 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Jeff Yass held 30,405 shares of Fulgent Genetics worth $624K as of Q2 2026.
  • Jeff Yass sold 7,673 Fulgent Genetics shares in Q2 2026, an estimated $130K.
  • Fulgent Genetics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #9385 holding.
  • Jeff Yass first reported a position in Fulgent Genetics in Q1 2018 and has held it in 26 quarters since.
  • Jeff Yass's Fulgent Genetics position peaked at $15.2M in Q2 2021.
  • 141 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.